Interleukin-2 (IL-2) Inhibitor Pipeline Insight 2025: Advancing Precision Immune Modulation
Interleukin-2 (IL-2) inhibitors represent a rapidly emerging category of immunomodulatory therapies designed to target IL-2 signaling, a pivotal pathway in immune system regulation. By selectively influencing IL-2 activity, these therapies aim to address a broad spectrum of autoimmune diseases, inflammatory conditions, and